Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood–brain barrier permeability: a preclinical systematic review and meta-analysis
To achieve sufficient blood–brain barrier (BBB), penetration is one of the biggest challenges in the development of diagnostic and therapeutic for central nervous system (CNS) disorders. Here, we conducted a systematic review and meta-analysis to assess the preclinical evidence and possible mechanis...
Main Authors: | Qun Zheng, Zi-Xian Chen, Meng-Bei Xu, Xiao-Li Zhou, Yue-Yue Huang, Guo-Qing Zheng, Yan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2018.1486471 |
Similar Items
-
Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability
by: Qun-Lin Zhang, et al.
Published: (2017-01-01) -
Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome
by: Yujia Zhang, et al.
Published: (2019-01-01) -
Enhanced permeability of blood–brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle
by: Song H, et al.
Published: (2018-03-01) -
Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability
by: Zhiyang Lv, et al.
Published: (2018-01-01) -
Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol
by: Rong Ma, et al.
Published: (2023-08-01)